Pediatrix Medical (MD) Short-term Investments (2009 - 2026)

Pediatrix Medical has disclosed Short-term Investments across 18 years of filings, most recently posting $123.2 million for Q1 2026.

• In Q1 2026, Short-term Investments rose 2.49% year-over-year to $123.2 million; the TTM figure through Mar 2026 stood at $123.2 million (up 2.49% YoY), while the FY2025 annual figure was $124.5 million, up 4.99% from the prior year.
• Short-term Investments slipped to $123.2 million in Q1 2026, from $124.5 million in the prior quarter.
• Over the last five years, Short-term Investments for MD reached as high as $124.5 million in Q4 2025 and fell as low as $89.6 million in Q1 2022.
• The 5-year median for Short-term Investments is $107.5 million (2024), against an average of $108.3 million.
• Annual changes were most pronounced in 2022 — Short-term Investments slipped 11.14% — and 2024, when it advanced 15.54%.
• A 5-year view of Short-term Investments shows it stood at $93.2 million in 2022, then climbed by 12.06% to $104.5 million in 2023, then advanced by 13.48% to $118.6 million in 2024, then grew by 4.99% to $124.5 million in 2025, then slipped by 1.03% to $123.2 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $123.2 million, $124.5 million, and $123.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.